Table 1. Data (point estimates) taken from Carabe-Fernandez et al [4] and used in this report.
| Assay | Low LET α/β | RBEmax | RBEmin |
| Oesophagus, LD50 | 16.24 | 3.05 | 2.27 |
| Bone marrow (haematocrit) | 1.15 | 26.33 | 1.19 |
| Kidney (EDTA) | 1.22 | 20.58 | 1.35 |
| Kidney | 2.23 | 15.85 | 0.73 |
| Mouse skin | 17.42 | 5.35 | 0.41 |
| Colorectal, LD50(2 months) | 28.96 | 5.70 | 1.46 |
| Colorectal, LD50(15 months) | 3.11 | 12.56 | 0.41 |
| Lung (28 weeks) | 2.93 | 7.63 | 0.58 |
| Lung LD50 (28 weeks) | 5.95 | 5.19 | 0.99 |
| Lung LD50 (68 weeks) | 2.32 | 8.62 | 0.72 |
| Pig skin (acute) | 15.17 | 3.46 | 0.71 |
| Pig skin (late) | 5.25 | 4.26 | 0.91 |
EDTA, ethylenediaminetetraacetic acid; LD50, lethal dose for 50%; LET, linear energy transfer; RBEmax, maximum value of relative biological effect; RBEmin, minimum value of relative biological effect.